For details regarding exhibiting at ACI 2018, please contact ACI@millbrookconferences.co.uk
Exhibition Floor Plan
To download a copy of the exhibition floor plan, please use the link below.Download
File size: 295.58 Kb
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Boston Scientific’s Interventional Cardiology division provides technologies for diagnosing and treating coronary artery disease, structural heart diseases and other cardiovascular disorders.
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations, and the burden of chronic disease — faced by families and healthcare systems today. But, we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com
Cordis is a leader in the development and manufacture of interventional technology with more than 50-years of delivering pioneering products to treat millions of patients worldwide.
We look forward to meeting you to discuss latest updates on the portfolio under Cardinal Health including the Railway Sheathless Access system, and two new distribution agreements with Biosensors & Kaneka that enables Cordis to sell coronary stents under the name LUMENO™ and Kaneka’s PTCA balloon catheters in EMEA.
As the leader in image guided therapy, we are committed to working with healthcare providers to help improve treatment for every patient. Our vision is to provide integrated solutions that advance minimally invasive procedures by helping healthcare providers to decide, guide, treat and confirm the right therapy for the right patient at the point of care. Working together to realize this vision, we can save and improve lives and reduce the total cost of care.
The HeartFlow® FFRCT Analysis is the first available non-invasive solution that enables clinicians to evaluate whether an individual has significant coronary artery disease based on both anatomy and physiology. Using data from a standard CT scan, the HeartFlow Analysis creates a personalized 3D model of the coronary arteries and analyzes the impact that blockages have on blood flow. The HeartFlow FFRCT Analysis is recommended by NICE for patients with stable recent onset chest pain.
ACIST is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange FFR and High Definition IVUS systems. We are also a global market leader in advanced contrast imaging systems for cardiovascular angiography with the CVi Contrast Injection System.
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
BCIS Welcomes New Companies